Categories: News

Kleiner Device Labs’ KG2 Surge Flow-Thru Interbody System Named Finalist for MD+DI Medical Design Excellence Award

INCLINE VILLAGE, Nev., March 31, 2022 /PRNewswire/ — Kleiner Device Labs today announced that its new KG2TM SurgeTM flow-thru interbody system has been selected as a finalist in the 2022 Medical Design Excellence awards in the Implant and Tissue-Replacement Products category.  The KG2 system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning and grafting processes for TLIF and PLIF spinal fusion procedures.  Medical Device + Diagnostic Industry (MD+DI) sponsors the annual awards to recognize superior design and engineering of products in the MedTech industry that improve health outcomes, quality and accessibility.

“Development of the company’s unique flow-thru technology and the new KG2 interbody system is the result of collaboration between surgical experience and mechanical engineering problem-solving, so we are proud to be recognized as a finalist,” said Alan Burkholder, chief technical officer of Kleiner Device Labs.   

The KG2 Surge system streamlines the implant delivery and grafting steps in lumbar spinal fusion procedures.  The system comes with the interbody device pre-assembled with the cannula in a single-use sterile tray.  It allows the surgeon to distract the disc space by inserting the implant, and then pack the disc space bilaterally through the KG2 Surge implant, using the attached cannulated inserter.  The implant’s I-beam architecture and ramp design, combined with the large cross-section cannula, allows simplified delivery and improved fill volume of a wide range of allograft and autograft products, including viscous and fibrous materials. 

A short video demonstrating how the KG2 Surge flow-thru interbody system works is available here.

For KG2 technical specifications, instructions for use, or clinical efficacy information, please go to the company’s web site.

About Kleiner Device Labs
Kleiner Device Labs is creating new instruments and devices to advance minimally invasive spine surgery and improve outcomes and costs for patients, surgeons, hospitals and payers.  Kleiner Device Labs is headquartered in Incline Village, Nevada.  More information is available on the company’s web site at http://www.kleinerlabs.com/.  

KG and Surge are trademarks of Kleiner Device Labs.

Sales and Surgeon Contact:
Mike Hughes
Mike.hughes@kleinerlabs.com
M: 949.632.0769

Media Contact:
Brad Samson                          
brad.samson@kleinerlabs.com                               
M: 714.955.3951

Investor Contact:
Stewart Peabody
Stew.peabody@kleinerlabs.com
M: 312.498.5892

MKT-00010-26 Rev 1

View original content to download multimedia:https://www.prnewswire.com/news-releases/kleiner-device-labs-kg2-surge-flow-thru-interbody-system-named-finalist-for-mddi-medical-design-excellence-award-301514655.html

SOURCE Kleiner Device Labs

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

6 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

9 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

9 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

9 hours ago